LeMaitre Vascular, Inc.
LMAT
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $1.9B
$81.72
▲ +0.79%
P/E
28.57
Mkt Cap
$1.9B
52-Wk Range
$78.27–$118.01
52-Week Range
$78.27 - $118.01
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 13.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Specialized focus on niche vascular intervention market with limited direct competition
- Comprehensive product portfolio addressing multiple steps in vascular procedures
- Established relationships with vascular surgeons and interventional radiologists worldwide
- Proprietary technology in carotid shunts and specialized catheter designs
Bear Case
2 risks
- Low volatility (beta 0.5).
- Premium valuation to Medical Devices peers
Growth
Stable outlook
Rising prevalence of peripheral vascular disease due to aging population and diabetes epidemic
Value
Premium valuation to Medical Devices peers
Momentum
Weak
-10.8% over 3m
Quality
Excellent
Strong fundamentals
Dividend
Modest
1.16% yield
Smart-money signal
Who's buying LMAT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 4, 2026
Reported EPS of $0.74 vs $0.81 consensus (-8.3% surprise). Revenue of $70.4M vs $71.5M expected (-1.5%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-8.3%
Revenue trend · last 8Q
—
+14%
+12%
+15%
+11%
+16%
+11%
+10%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$54.8M
$55.7M
$59.9M
$64.2M
$61.0M
$64.5M
$66.6M
$70.4M
Margins · last 8Q
Gross
72.1%
Operating
29.0%
Profit
24.2%
Wall Street consensus
3 analysts · 67% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
67%
Hold
33%
Sell
0%
Median Price Target
—
Latest: Barrington · $120.00 · May 6, 2026
vs Industry
How LMAT stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related